Clinical trial
Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With…
NCT00277667 · Lindner Center of HOPE, Other · Completed
Key facts
| NCT number | NCT00277667 |
|---|---|
| Title | Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms |
| Lead sponsor | Lindner Center of HOPE, Other |
| Collaborators | AstraZeneca Industry University of Cincinnati |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Quetiapine |
| Enrollment | 40 |
| Start date | Feb 1, 2004 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Jan 16, 2006 |
| Last update posted | Mar 13, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: